The U.S. Department of Health & Human Services (HHS) requires a vendor(s) to distribute pre-exposure prophylaxis (PrEP) medications as part of a donation agreement between HHS and Gilead to provide PrEP medication at no cost for up to 200,000 individuals a year who are at risk for HIV and who are uninsured.

PrEP medication is a prevention tool that is critical to the Department’s initiative to end the HIV epidemic in 10 years and is available to qualified individuals through HHS’s nationwide Ready, Set, PrEP program.

HHS has released a request for proposals (RFP) for a full and open competition to select an awardee(s) to administer an integrated, nationwide, medication-distribution system for Ready, Set, PrEP, with a period of performance with a 12-month base period plus four (4) 12-month option periods. Learn more here.